19900 MACARTHUR BLVD., IRVINE, CA
Reports Second Quarter 2025 Operating and Financial Results
Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
News, Articles of Incorporation, Bylaws
Earnings Release
Annual Report to Security Holders
Amended material disclosure
News, Letter Re Change in Certifying Accountant
Reports Fourth Quarter and Full Year 2024 Operating and Financial Results
Q2
Amended Quarterly Report
Amended Annual Report
Q1
FY 2024
Q3
Q2 amended
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(3)
Notice of Exempt Offering of Securities
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload